|
🐜
|
Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative
35 auth.
D. Aletaha,
T. Neogi,
A. Silman,
Julia Funovits,
D. Felson,
C. Bingham,
N. Birnbaum,
G. Burmester,
V. Bykerk,
M. Cohen,
B. Combe,
K. Costenbader,
M. Dougados,
P. Emery,
G. Ferraccioli,
...
J. Hazes,
K. Hobbs,
T. Huizinga,
A. Kavanaugh,
J. Kay,
T. Kvien,
T. Laing,
P. Mease,
H. Ménard,
L. Moreland,
R. Naden,
T. Pincus,
J. Smolen,
E. Stanisławska-Biernat,
D. Symmons,
P. Tak,
K. Upchurch,
Í. Vencovský,
F. Wolfe,
G. Hawker
|
12 |
2010 |
12
🐜
|
|
🐜
|
UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha,
35 auth.
D. Aletaha,
T. Neogi,
A. Silman,
Julia Funovits,
D. Felson,
C. Bingham,
N. Birnbaum,
G. Burmester,
V. Bykerk,
M. Cohen,
B. Combe,
K. Costenbader,
M. Dougados,
P. Emery,
G. Ferraccioli,
...
J. Hazes,
K. Hobbs,
T. Huizinga,
A. Kavanaugh,
J. Kay,
T. Kvien,
T. Laing,
P. Mease,
H. Ménard,
L. Moreland,
R. Naden,
T. Pincus,
J. Smolen,
E. Stanisławska-Biernat,
D. Symmons,
P. Tak,
K. Upchurch,
Í. Vencovský,
F. Wolfe,
G. Hawker
|
11 |
2010 |
11
🐜
|
|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
35 auth.
J. Smolen,
R. Landewé,
F. Breedveld,
M. Dougados,
P. Emery,
C. Gaujoux-Viala,
S. Gorter,
R. Knevel,
J. Nam,
M. Schoels,
D. Aletaha,
M. Buch,
L. Gossec,
T. Huizinga,
J. Bijlsma,
...
G. Burmester,
B. Combe,
M. Cutolo,
C. Gabay,
J. Gómez-Reino,
M. Kouloumas,
T. Kvien,
E. Martı́n-Mola,
I. McInnes,
K. Pavelka,
P. V. van Riel,
Marieke Scholte,
D. Scott,
T. Sokka,
G. Valesini,
R. V. van Vollenhoven,
K. Winthrop,
J. Wong,
A. Zink,
D. M. van der Heijde
|
11 |
2010 |
11
🐜
|
|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
49 auth.
J. Smolen,
R. Landewé,
J. Bijlsma,
G. Burmester,
K. Chatzidionysiou,
M. Dougados,
J. Nam,
S. Ramiro,
M. Voshaar,
R. V. van Vollenhoven,
D. Aletaha,
M. Aringer,
M. Boers,
C. Buckley,
F. Buttgereit,
...
V. Bykerk,
M. Cardiel,
B. Combe,
M. Cutolo,
Y. van Eijk-Hustings,
P. Emery,
A. Finckh,
C. Gabay,
J. Gómez-Reino,
L. Gossec,
J. Gottenberg,
J. Hazes,
T. Huizinga,
M. Jani,
D. Karateev,
M. Kouloumas,
T. Kvien,
Zhanguo Li,
X. Mariette,
I. McInnes,
E. Mysler,
P. Nash,
K. Pavelka,
G. Poór,
C. Richez,
P. V. van Riel,
A. Rubbert-Roth,
K. Saag,
J. D. da Silva,
T. Stamm,
T. Takeuchi,
R. Westhovens,
M. D. de Wit,
D. M. van der Heijde
|
11 |
2010 |
11
🐜
|
|
🐜
|
Treating rheumatoid arthritis to target: recommendations of an international task force
22 auth.
J. Smolen,
D. Aletaha,
J. Bijlsma,
F. Breedveld,
D. Boumpas,
G. Burmester,
B. Combe,
M. Cutolo,
Maarten de Wit,
M. Dougados,
...
P. Emery,
A. Gibofsky,
J. Gómez-Reino,
B. Haraoui,
J. Kalden,
E. Keystone,
T. Kvien,
I. McInnes,
E. Martı́n-Mola,
C. Montecucco,
M. Schoels,
D. M. van der Heijde
|
10 |
2010 |
10
🐜
|
|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
47 auth.
J. Smolen,
R. Landewé,
J. Bijlsma,
G. Burmester,
M. Dougados,
A. Kerschbaumer,
I. McInnes,
A. Sepriano,
R. V. van Vollenhoven,
M. D. de Wit,
D. Aletaha,
M. Aringer,
J. Askling,
A. Balsa,
M. Boers,
...
A. D. den Broeder,
M. Buch,
F. Buttgereit,
R. Caporali,
M. Cardiel,
D. De Cock,
C. Codreanu,
M. Cutolo,
C. Edwards,
Y. van Eijk-Hustings,
P. Emery,
A. Finckh,
L. Gossec,
J. Gottenberg,
M. Hetland,
T. Huizinga,
Marios Koloumas,
Zhanguo Li,
X. Mariette,
U. Müller-Ladner,
E. Mysler,
J. D. da Silva,
G. Poór,
J. Pope,
A. Rubbert-Roth,
A. Ruyssen-witrand,
K. Saag,
A. Strangfeld,
T. Takeuchi,
M. Voshaar,
R. Westhovens,
D. M. van der Heijde
|
10 |
2020 |
10
🐜
|
|
🐜
|
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
13 auth.
S. Cohen,
P. Emery,
M. Greenwald,
M. Dougados,
R. Furie,
M. Genovese,
E. Keystone,
J. Loveless,
G. Burmester,
M. Cravets,
...
E. Hessey,
T. Shaw,
M. Totoritis
|
10 |
2006 |
10
🐜
|
|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
33 auth.
J. Smolen,
R. Landewé,
F. Breedveld,
M. Buch,
G. Burmester,
M. Dougados,
P. Emery,
C. Gaujoux-Viala,
L. Gossec,
J. Nam,
S. Ramiro,
K. Winthrop,
M. D. de Wit,
D. Aletaha,
N. Betteridge,
...
J. Bijlsma,
M. Boers,
F. Buttgereit,
B. Combe,
M. Cutolo,
N. Damjanov,
J. Hazes,
M. Kouloumas,
T. Kvien,
X. Mariette,
K. Pavelka,
P. V. van Riel,
A. Rubbert-Roth,
M. Scholte-Voshaar,
D. Scott,
T. Sokka-Isler,
J. Wong,
D. M. van der Heijde
|
10 |
2013 |
10
🐜
|
|
🐜
|
Rheumatoid arthritis
11 auth.
J. Smolen,
D. Aletaha,
A. Barton,
G. Burmester,
P. Emery,
G. Firestein,
...
A. Kavanaugh,
I. McInnes,
D. Solomon,
V. Strand,
Kazuhiko Yamamoto
|
10 |
2018 |
10
🐜
|
|
🐜
|
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
43 auth.
J. Smolen,
F. Breedveld,
G. Burmester,
V. Bykerk,
M. Dougados,
P. Emery,
T. Kvien,
M. V. Navarro-Compán,
S. Oliver,
M. Schoels,
M. Scholte-Voshaar,
T. Stamm,
M. Stoffer,
T. Takeuchi,
D. Aletaha,
...
J. Andreu,
M. Aringer,
Martin Bergman,
N. Betteridge,
H. Bijlsma,
H. Burkhardt,
M. Cardiel,
B. Combe,
P. Durez,
J. Fonseca,
A. Gibofsky,
J. Gómez-Reino,
W. Graninger,
P. Hannonen,
B. Haraoui,
M. Kouloumas,
R. Landewé,
E. Martı́n-Mola,
P. Nash,
M. Ostergaard,
A. Östör,
P. Richards,
T. Sokka-Isler,
C. Thorne,
A. Tzioufas,
R. V. van Vollenhoven,
M. D. de Wit,
D. M. van der Heijde
|
10 |
2015 |
10
🐜
|
|
🐜
|
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
28 auth.
L. Gossec,
X. Baraliakos,
A. Kerschbaumer,
M. D. de Wit,
I. McInnes,
M. Dougados,
J. Primdahl,
D. McGonagle,
D. Aletaha,
A. Balanescu,
P. Bálint,
H. Bertheussen,
W. Boehncke,
G. Burmester,
J. Cañete,
...
N. Damjanov,
T. Kragstrup,
T. Kvien,
R. Landewé,
R. Lories,
H. Marzo-Ortega,
D. Poddubnyy,
Santiago Rodrigues Manica,
G. Schett,
D. Veale,
F. E. Van den Bosch,
D. M. van der Heijde,
J. Smolen
|
9 |
2020 |
9
🐜
|
|
🦁
|
Novel treatment strategies in rheumatoid arthritis
G. Burmester,
J. Pope
|
9 |
2017 |
9
🦁
|
|
🐜
|
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
12 auth.
T. Schnitzer,
G. Burmester,
E. Mysler,
M. Hochberg,
M. Doherty,
E. Ehrsam,
...
X. Gitton,
G. Krammer,
B. Mellein,
P. Matchaba,
A. Gimona,
C. Hawkey
|
9 |
2004 |
9
🐜
|
|
🐜
|
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris
39 auth.
D. Pathirana,
A. Ormerod,
P. Saiag,
Catherine Smith,
P. Spuls,
A. Nast,
J. Barker,
J. Bos,
G. Burmester,
S. Chimenti,
L. Dubertret,
B. Eberlein,
R. Erdmann,
J. Ferguson,
G. Girolomoni,
...
P. Gisondi,
A. Giunta,
C. Griffiths,
H. Hönigsmann,
M. Hussain,
R. Jobling,
S. Karvonen,
L. Kemény,
I. Kopp,
C. Leonardi,
M. Maccarone,
A. Menter,
U. Mrowietz,
L. Naldi,
T. Nijsten,
Ortonne Jp,
H. Orzechowski,
T. Rantanen,
K. Reich,
N. Reytan,
H. Richards,
H. Thio,
P. Kerkhof,
B. Rzany
|
9 |
2009 |
9
🐜
|
